Actively Recruiting

Phase Not Applicable
Age: 50Years +
All Genders
NCT06689839

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

Led by EnCompass Technologies, Inc. · Updated on 2025-11-20

500

Participants Needed

10

Research Sites

68 weeks

Total Duration

On this page

Sponsors

E

EnCompass Technologies, Inc.

Lead Sponsor

A

Avania

Collaborating Sponsor

AI-Summary

What this Trial Is About

The objective of this study is to compare the safety and effectiveness of the F2 Cerebral Protection System (CPS) to a standard of care control group in patients undergoing Transcatheter Aortic Valve Replacement (TF TAVR)

CONDITIONS

Official Title

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

Who Can Participate

Age: 50Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 50 years or older
  • Scheduled to undergo Transfemoral Transcatheter Aortic Valve Replacement (TAVR) per physician's indication
  • Willing and able to comply with protocol follow-up evaluations
  • Able and willing to provide written informed consent
  • Meets criteria for use of the control device (Sentinel device) per instructions for use
Not Eligible

You will not qualify if you...

  • Requires urgent or emergent TAVR procedure
  • Any interventional cardiovascular procedure within 30 days before or planned within 30 days after TAVR
  • Diagnostic cardiac catheterization within 10 days before TAVR
  • Acute myocardial infarction within 3 months prior to TAVR
  • Prior prosthetic heart valve in any position
  • Known intracardiac thrombus
  • Active infection or endocarditis
  • Contraindications to anti-platelet or anticoagulant therapy
  • Refusal of blood transfusion
  • Renal insufficiency with creatinine > 2.5 mg/dL or GFR < 30, or on renal replacement therapy
  • Hepatic failure (Child-Pugh class C)
  • Severe ventricular dysfunction with LVEF < 30%
  • Females who are pregnant, nursing, or planning pregnancy during study participation
  • Modified Rankin Scale score ≥ 2 at screening
  • Cerebrovascular event including TIA within 6 months before procedure
  • Active major psychiatric disease or history of substance abuse affecting compliance
  • Severe visual, auditory, or learning impairments
  • Neurodegenerative or other progressive neurological diseases, significant head trauma with persistent deficits, or known brain abnormalities
  • Contraindications to MRI including unsafe implants, metal fragments, or clips in brain or eye before TAVR
  • High risk of complete AV block after TAVR requiring permanent pacemaker
  • Claustrophobia preventing MRI scans
  • Severe peripheral, abdominal, or thoracic aortic disease preventing device delivery or filter deployment
  • Cardiovascular implants in aorta or peripheral access vessels
  • Access vessels with excessive tortuosity
  • Severely calcified, atheromatous, or tortuous aortic arch

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 10 locations

1

NCH Baker Hospital-Naples Heart Institute

Naples, Florida, United States, 34102

Not Yet Recruiting

2

St. Vincent Hospital

Indianappolis, Indiana, United States, 46260

Actively Recruiting

3

Henry Ford Hospital

Detroit, Michigan, United States, 48202

Actively Recruiting

4

St. Lukes Hospital Of Kansas City

Kansas City, Missouri, United States, 64111

Actively Recruiting

5

Cumc/Nyph

New York, New York, United States, 10032

Actively Recruiting

6

Cleveland Clinic Foundation

Cleveland, Ohio, United States, 44195

Actively Recruiting

7

Ohio Health Research Institute (aka Riverside Methodist Hospital)

Columbus, Ohio, United States, 43214

Not Yet Recruiting

8

University of Virginia Medical Center

Charlottesville, Virginia, United States, 22903

Not Yet Recruiting

9

St Andrews War Memorial Hospital

Spring Hill, Queensland, Australia, 4000

Not Yet Recruiting

10

Monash Health Public

Clayton, Victoria, Australia, 3168

Actively Recruiting

Loading map...

Research Team

K

Kathleen S Calderon

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR | DecenTrialz